Healthcare provider profile · identity verified

Jorge Ulises Rubi, MD

Internal Medicine · YORK, PA · NPI 1245261882

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	437	123
Atorvastatin Calcium	Atorvastatin Calcium	390	98
Amlodipine Besylate	Amlodipine Besylate	363	99
Omeprazole	Omeprazole	345	93
Levothyroxine Sodium	Levothyroxine Sodium	333	82
Rosuvastatin Calcium	Rosuvastatin Calcium	271	83
Metoprolol Succinate	Metoprolol Succinate	231	63
Lisinopril	Lisinopril	222	59
Prednisone	Prednisone	217	110
Tamsulosin Hcl	Tamsulosin Hcl	215	59
Escitalopram Oxalate	Escitalopram Oxalate	206	54
Simvastatin	Simvastatin	202	55
Gabapentin	Gabapentin	189	53
Hydrochlorothiazide	Hydrochlorothiazide	187	53
Pantoprazole Sodium	Pantoprazole Sodium	180	51
Atenolol	Atenolol	179	51
Metformin Hcl	Metformin Hcl	175	53
Furosemide	Furosemide	172	47
Pravastatin Sodium	Pravastatin Sodium	154	38
Alprazolam	Alprazolam	152	35
Eliquis	Apixaban	151	31
Metoprolol Tartrate	Metoprolol Tartrate	143	40
Amitriptyline Hcl	Amitriptyline Hcl	136	34
Lorazepam	Lorazepam	135	36
Sertraline Hcl	Sertraline Hcl	128	31
Clopidogrel	Clopidogrel Bisulfate	116	32
Allopurinol	Allopurinol	114	31
Meloxicam	Meloxicam	113	46
Famotidine	Famotidine	102	29
Finasteride	Finasteride	96	25
Albuterol Sulfate Hfa	Albuterol Sulfate	88	38
Fluticasone Propionate	Fluticasone Propionate	88	27
Valsartan	Valsartan	88	20
Bupropion Xl	Bupropion Hcl	67	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	62	46
Tramadol Hcl	Tramadol Hcl	62	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	27
Doxycycline Hyclate	Doxycycline Hyclate	60	40
Trazodone Hcl	Trazodone Hcl	60	20
Paroxetine Hcl	Paroxetine Hcl	58	12
Venlafaxine Hcl Er	Venlafaxine Hcl	58	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	57	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	53	45
Carvedilol	Carvedilol	53	14
Oxycodone Hcl	Oxycodone Hcl	52	suppressed
Amoxicillin	Amoxicillin	51	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	14
Glimepiride	Glimepiride	48	13
Donepezil Hcl	Donepezil Hcl	47	11
Azithromycin	Azithromycin	46	44
Montelukast Sodium	Montelukast Sodium	46	13
Spironolactone	Spironolactone	46	11
Xarelto	Rivaroxaban	46	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	11
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Methylprednisolone	Methylprednisolone	40	32
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Synthroid	Levothyroxine Sodium	37	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	14
Azelastine Hcl	Azelastine Hcl	35	suppressed
Celecoxib	Celecoxib	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Nitroglycerin	Nitroglycerin	33	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	25
Esomeprazole Magnesium	Esomeprazole Magnesium	30	11
Metformin Hcl Er	Metformin Hcl	30	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	12
Bumetanide	Bumetanide	28	suppressed
Diazepam	Diazepam	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Dutasteride	Dutasteride	26	suppressed
Risperidone	Risperidone	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Warfarin Sodium	Warfarin Sodium	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Sucralfate	Sucralfate	20	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Glipizide	Glipizide	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Dilantin	Phenytoin Sodium Extended	16	suppressed
Econazole Nitrate	Econazole Nitrate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Ramipril	Ramipril	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Dilantin	Phenytoin	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Selegiline Hcl	Selegiline Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Ozempic	Semaglutide	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error